Tesamorelin: A Research Overview
17 June 2026
Tesamorelin is a synthetic peptide studied as a growth-hormone-releasing hormone (GHRH) analogue. It features prominently in research examining the regulation of the growth-hormone axis.
What is Tesamorelin?
Tesamorelin is a stabilised analogue of GHRH, the hypothalamic hormone that prompts the pituitary to release growth hormone. In research it is used as a tool to study GHRH-receptor signalling.
Pathways studied in the literature
- Stimulation of endogenous growth-hormone release via the GHRH receptor.
- Downstream effects on IGF-1 in laboratory and clinical research.
- Metabolic endpoints, including studies on visceral adipose tissue.
Summary of research findings
Tesamorelin has been the subject of clinical research programmes examining growth-hormone-axis and metabolic endpoints. Within a research setting it is studied as a model GHRH analogue. Findings should be interpreted in the context of each study's design.
The research described here refers to laboratory and preclinical studies. Defined Labs products are supplied strictly for in vitro research use only.
Related compounds
This guide is for educational purposes and refers to laboratory and preclinical research. All Defined Labs products are supplied strictly for in vitro research use only and are not intended for human or veterinary use, consumption, or any clinical purpose.